To further confirm the synergy effects of etoposide and MK2.III on p53 mutant cancer cells, additional CCK8 cell viability analysis of MDA-MB-231 breast cancer cell line, and SW620, and SW480 colorectal cancer cell lines was performed (Fig. 5). Here, TP53 is linked to colorectal cancer.